Skip to content

TMO

Thermo Fisher Scientific Inc.

Operating income, 2025
$7.7B
YoY, 2025
+5.6%
5-year CAGR
−0.1%
10-year CAGR
+12.7%

Operating income

Operating income by fiscal year

PeriodOperating incomeYoY
2025$7.7B+5.6%
2024$7.3B+7.0%
2023$6.9B−18.3%
2022$8.4B−16.3%
2021$10.0B+28.7%
2020$7.8B+69.7%
2019$4.6B+21.4%
2018$3.8B+27.8%
2017$3.0B+20.4%
2016$2.5B+5.2%
2015$2.3B−6.7%
2014$2.5B+55.5%
2013$1.6B+8.6%
2012$1.5B+18.5%
2011$1.3B+5.3%
2010$1.2B+18.6%
2009$1.0B−18.5%
2008$1.2B+26.2%
2007$974M—